Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available |
c.1 BC Cancer Agency VIC Library | On Loan, due Wednesday, June 5, 2024 | ||
c.4 BC Cancer Agency VAN Library | On Loan, due Tuesday, June 11, 2024 | ||
c.2 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.3 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.2 BC Cancer Agency ARHCC Library | Available | ||
c.2 BC Cancer Agency CN Library Missing | Available | ||
c.1 BC Cancer Agency KEL Library Missing | Available | ||
c.2 BC Cancer Agency KEL Library | Available | ||
c.7 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency SUR Library Missing | Available | ||
c.2 BC Cancer Agency VAN Library | Available | ||
c.5 BC Cancer Agency VAN Library | Available | ||
c.3 BC Cancer Agency VIC Library | Available | ||
c.3 BC Cancer Agency ARHCC Library | Available | ||
c.6 BC Cancer Agency VAN Library | Available | ||
c.3 BC Cancer Agency KEL Library | Available | ||
c.3 BC Cancer Agency CN Library | Available | ||
c.1 BC Cancer Agency CN Library | Available | ||
c.4 BC Cancer Agency SUR Library Missing | Available |
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency CN Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency VAN Library | Available | ||
c.3 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency CN Library | Available |
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
Contents:; Introduction : First Nations, Métis, and Inuit in Canada : Understanding the Issues -- Western and Indigenous Ways of Knowing -- Cultural Competency, Cultural Sensitivity and Cultural Safety -- Historical Overview -- Understanding the Determinants of Health and Canada?s Native Popu…
c.1 BC Cancer Agency KEL Library | On Loan, due Wednesday, June 5, 2024 | ||
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency KEL Library | Available |
Table of Contents:; 1 Biology of Cancer -- 2 Staging and Performance Status -- 3 Cancer Epidemiology and Prevention -- 4 Genetic Risk for Developing Cancer -- 5 Cancer Detection Measures -- 6 Pharmacogenomics -- 7 Surgery -- 8 Radiation Therapy -- 9 Chemotherapy -- 10 Precision Medicine: Biologics …
c.1 BC Cancer Agency KEL Library | On Loan, due Wednesday, June 19, 2024 | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency CN Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency KEL Library | On Loan, due Monday, May 6, 2024 | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available |
Table of Contents:; 1. Immunotherapy administration; 2. Immunotherapy; 3. Cancer immunotherapy; 4. CAR T-cell therapy; 5. Cytokine release syndrome; 6. Developming infrastructure; 7. Immunotherapy toxicities; 8. Checkpoint inhibitors; 9. Toxicity managment; 10.Oncolytic viruses
c.1 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency CN Library Missing | Available | ||
c.2 BC Cancer Agency SUR Library | Available |
c.1 BC Cancer Agency VAN Library | On Loan, due Monday, March 11, 2024 | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency SUR Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.2 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency CN Library | Available |
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency KEL Library | Available |
Coronary artery disease, peripheral vascular disease (PVD), renal artery stenosis, lung cancer screening, pulmonary embolism (PE), carotid artery disease, cerebral aneurysms, headaches, head injuries, seizures, stroke, arteriovenous malformations (AVMs), and urinary tract calculi screening
c.1 BC Cancer Agency KEL Library | Available |
Contents:; Survivorship / Symptom management / Psychological distress / Family relationships, social support, fear of recurrence, and finances / Spirituality / Pediatric/family concerns posttreatment / Theory of uncertainty / Theory of unpleasant symptoms / Transitions / Adaptation / Resilience / O…
c.1 BC Cancer Agency KEL Library | Available |